UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of simvastatin and atorvastatin on inflammation markers in plasma

Journal of internal medicine, 2002-04, Vol.251 (4), p.338-347

2002

Volltextzugriff (PDF)

Increased lipolysis by secretory phospholipase A2 group V of lipoproteins in diabetic dyslipidaemia

Journal of internal medicine, 2008-08, Vol.264 (2), p.155-165

2008

Volltextzugriff (PDF)

Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes

Journal of internal medicine, 2004-08, Vol.256 (2), p.119-127

2004

Volltextzugriff (PDF)

Proprotein convertase subtilisin/kexin 6 is involved in lipid metabolism in liver and adipose tissue

ATHEROSCLEROSIS, 2021-08, Vol.331, p.e4-e4

2021

Volltextzugriff (PDF)

ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model

Journal of lipid research, 2020-03, Vol.61 (3), p.272-274

Hurt-Camejo, Eva

2020

Volltextzugriff (PDF)

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease

Scandinavian journal of rheumatology, 2009-01, Vol.38 (3), p.184-189

2009

Volltextzugriff (PDF)

Inhibition of secretory phospholipase A2 ( s PLA2) caused rapid changes in plasma HDL composition and function in apoE Leiden x hCETP mice and reduced the ex-vivo enzyme effects: potential impact in its athero-protective properties

Atherosclerosis, 2014-08, Vol.235 (2), p.e76-e77

2014

Volltextzugriff (PDF)

Increased lipoprotein binding to arterial proteoglycans and normal macrophage cholesterol efflux capacity define the pro-atherogenic feature of CKD dyslipidemia

Atherosclerosis, 2016-09, Vol.252, p.e237-e237

2016

Volltextzugriff (PDF)

Phospholipase A2 enzymes and the risk of atherosclerosis

European heart journal, 2012-12, Vol.33 (23), p.2899-2909

2012

Volltextzugriff (PDF)

Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells

The Journal of biological chemistry, 1993-07, Vol.268 (19), p.14131-14137

1993

Volltextzugriff (PDF)

Why are brown bears protected against atherosclerosis even though their plasma cholesterol levels are twice that of humans?

Clínica e investigación en arteriosclerosis, 2022-11, Vol.34 (6), p.322

2022

Volltextzugriff (PDF)

Does statins promote vascular calcification in chronic kidney disease?

European journal of clinical investigation, 2017-02, Vol.47 (2), p.137-148

2017

Volltextzugriff (PDF)

3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr−/− mice

Cardiovascular research, 2020-10, Vol.116 (12), p.1948-1957

2020

Volltextzugriff (PDF)

Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia

Journal of internal medicine, 2008-08, Vol.264 (2), p.155-165

2008

Volltextzugriff (PDF)

Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines

The Journal of biological chemistry, 2000-07, Vol.275 (30), p.22895-22904

2000

Volltextzugriff (PDF)

Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism

Biology, 2015-02, Vol.4 (1), p.104-132

2015

Volltextzugriff (PDF)

Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)

Journal of lipid research, 2021-01, Vol.62, p.100065, Article 100065

2021

Volltextzugriff (PDF)

Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemia

Journal of internal medicine, 2001-05, Vol.249 (5), p.441-449

2001

Volltextzugriff (PDF)

ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker

Journal of cardiovascular development and disease, 2018-07, Vol.5 (3), p.36

2018

Volltextzugriff (PDF)

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages

Journal of lipid research, 1990-08, Vol.31 (8), p.1387-1398

1990

Volltextzugriff (PDF)

Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease

Frontiers in pharmacology, 2022-09, Vol.13, p.988561-988561

2022

Volltextzugriff (PDF)

ATHERO-PROTECTIVE PROPERTIES OF PLASMA LIPOPROTEINS FROM BROWN BEARS (URSUS ARCTOS) DURING HIBERNATION AND ACTIVE STATE

ATHEROSCLEROSIS, 2020, Vol.315, p.E69

2020

Volltextzugriff (PDF)

Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages

Inflammation research, 2006-07, Vol.55 (7), p.300-309

2006

Volltextzugriff (PDF)

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Atherosclerosis, 2003-02, Vol.166 (2), p.387-394

2003

Volltextzugriff (PDF)

Phospholipase A(2) in vascular disease

Circulation research, 2001-08, Vol.89 (4), p.298-304

2001

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(111)
Tagungsberichte
(5)

Sprache

Englisch
(114)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of simvastatin and atorvastatin on inflammation markers in plasma

Increased lipolysis by secretory phospholipase A2 group V of lipoproteins in diabetic dyslipidaemia

Low‐grade inflammation, endothelial activation and carotid intima‐media thickness in type 2 diabetes

Proprotein convertase subtilisin/kexin 6 is involved in lipid metabolism in liver and adipose tissue

ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease

Inhibition of secretory phospholipase A2 ( s PLA2) caused rapid changes in plasma HDL composition and function in apoE Leiden x hCETP mice and reduced the ex-vivo enzyme effects: potential impact in its athero-protective properties

Increased lipoprotein binding to arterial proteoglycans and normal macrophage cholesterol efflux capacity define the pro-atherogenic feature of CKD dyslipidemia

Phospholipase A2 enzymes and the risk of atherosclerosis

Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells

Why are brown bears protected against atherosclerosis even though their plasma cholesterol levels are twice that of humans?

Does statins promote vascular calcification in chronic kidney disease?

3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr−/− mice

Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia

Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines

Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism

Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)

Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemia

ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages

Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease

ATHERO-PROTECTIVE PROPERTIES OF PLASMA LIPOPROTEINS FROM BROWN BEARS (URSUS ARCTOS) DURING HIBERNATION AND ACTIVE STATE

Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Phospholipase A(2) in vascular disease

Suchergebnisse filtern